• Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
HBOT News Network Logo
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications
Veterans Special Report
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications

Paradigm shifts in the management of osteoradionecrosis of the mandible.

by HBOT News | Aug 17, 2010 | Carcinoma

Abstract: Osteoradionecrosis (ORN) of the mandible is a significant complication of radiation therapy for head and neck cancer. In this condition, bone within the radiation field becomes devitalized and exposed through the overlying skin or mucosa, persisting as a...

Gastrointestinal toxicity associated to radiation therapy.

by HBOT News | Aug 17, 2010 | Cancer

Abstract: Radiation therapy in combination with other treatments, such as surgery and chemotherapy, increases locoregional control and survival in patients with thoracic, abdominal and pelvic malignancies. Nevertheless, significant clinical toxicity with combined...

Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells.

by HBOT News | Jul 13, 2010 | Carcinoma

Abstract: TNF-related apoptosis-inducing ligand (TRAIL, Apo2L) is a promising anticancer agent with high specificity for cancer cells. Many strategies have been proposed to enhance the sensitivity of cancer cells to TRAIL-mediated apoptosis, including the use of...

Safety and efficacy of early postoperative hyperbaric oxygen therapy with restriction of transfusions in patients with HCC who have undergone partial hepatectomy.

by HBOT News | Jul 1, 2010 | Carcinoma

Abstract: Recent studies have shown that intraoperative blood loss and blood transfusions promote postoperative recurrence of hepatocellular carcinoma (HCC). Hyperbaric oxygen therapy (HBOT) is a specific method of oxygen administration, which is independent of fluid...

Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions.

by HBOT News | Jun 22, 2010 | Cancer

Abstract: Hypoxia, which is commonly observed in many solid tumors, is a major impediment to chemo- or radiation therapy. Hypoxia is also known to overexpress/activate signal transducer and activator of transcription 3 (STAT3) leading to tumor progression as well as...
« Older Entries
Next Entries »

Recent Posts

  • Treat the Concussion: How HBOT Is Changing the Playbook for Concussions — An Interview with Dr. Daphne Denham
  • Understanding Hyperbaric Chambers: Types, Risks, and Safety Tips for Patients
  • Overcoming the Placebo Challenge: New Trial Confirms HBOT Benefits for TBI and PTSD
  • Concussion Recovery: New Study Supports HBOT for Student Athletes
  • Can Oxygen Make You Younger? What Bryan Johnson’s $2M HBOT Experiment Really Tells Us

Archives

Categories

Hyperbaric Oxygen Therapy is used around the world to extend and improve quality of life by augmenting the treatment of all injuries, diseases and infections, as well as to improve overall wellness. HBOT involves breathing 100% oxygen in a pressurized chamber to increase oxygen levels in blood plasma. A century of clinical research has shown that increased oxygen in plasma accelerates our natural ability to heal through neurogenesis and angiogenesis.
  • Follow
  • Follow
  • Follow
  • Follow
  • Policies
  • Contact

Our Newsletter

Join our mailing list and get notified when we publish news or record new episodes.

Name(Required)

© 2015-2023 HBOT News – Your news source for the latest news and research about hyperbaric oxygen therapy.